Micron Lights the Fuse: Semis Rip, Two Fresh Beats, and a Merck Takeout
SignalDeck Premarket · Thursday, June 25, 2026
Situational Awareness
🚀 Micron’s blowout ignited a full semiconductor rally. MU is +18.8% premarket ($1,245) after last night’s print and ~$50B revenue guide, and the entire memory/AI-infra complex is ripping with it: SanDisk +17%, Western Digital +14%, Seagate +12%, plus Lam Research and Applied Materials +7%. S&P futures are higher. The two-day rout is now a two-day-ago memory.
🌡️ PCE ran hot — but in line. May core PCE rose to 3.4% YoY (headline ~4%, highest since 2023), roughly as expected. Markets still price ~70% odds of a Fed hike by September, but the semi melt-up is overpowering the inflation print this morning.
🛢️ Oil under $72 (lowest since February); gold −2%, silver −4% — miners pressured (Newmont −3%). The risk-on bid is concentrated in chips, not commodities.
📅 Russell reconstitution finalizes after tomorrow’s close (6/26), effective Monday — forced index flows into the weekend.
Top Calls
A semi-led tape. MU (banked last night) leads; two new earnings beats (SNX, BB), a confirmed M&A takeout (TECH), and a biotech data-timeline catalyst (KYMR) round it out. Sympathy names get no EP-γ.
MU +18.8% · fresh-EP · STRONG-borderline (EP-γ 74) · High — The blowout is extending; ~$50B next-quarter guide and “tightness beyond 2027.” (Banked 6/24; D1 review marks at today’s close.)
TECH +19.4% · M&A · Low — Merck KGaA is acquiring Bio-Techne for $73/share cash (~$11.3B, 36% premium), board-approved, closing late-2026/early-2027. Trading ~$70 = ~4% to the deal; this is arb, bounded by the price, not a momentum runner.
SNX +8.9% · fresh-EP (vol-gated) · Watch — TD Synnex posted a record Q2: EPS $4.85 vs $4.11, revenue $19.6B (+31% YoY) vs ~$16.8B, and raised its Q3 guide above consensus on Hyve/AI-server strength. Genuinely high-quality — but premarket volume (0.5x) fails our EP gate, so no confirmation yet.
KYMR +8.8% · news_driven (clinical) · Med — Kymera pulled forward the topline-data timeline for KT-621, its oral STAT6 degrader in Phase 2b for atopic dermatitis (eczema). An accelerated readout on a lead program.
BB +9.1% · fresh-EP · CAND (58) · Med — BlackBerry beat (EPS surprise +36%, revenue +9%) on IoT/QNX automotive and cybersecurity; a modest but clean EP that cleared scoring.
QCOM +10.4% · news_driven (Investor Day) · — Yesterday’s Meta data-center-CPU re-rate continuing. (Banked 6/24; D1 marks today.)
⚠ SMCI · governance (CAUTION) — Rallying with the semis, but it carries a standing governance flag (2018 SEC settlement, 2024 auditor resignation, 2026 DOJ indictment). Surfaced with the risk note, not as a clean call.
The Setups
MU + the semi complex
One print, a sector on fire. Micron’s ~$50B revenue guide and multi-year tightness message didn’t just lift Micron (+18.8%) — it re-rated the whole memory and semicap chain. SanDisk (+17%), Western Digital (+14%), and Seagate (+12%) are the direct memory read-through; Lam Research and Applied Materials (+7%) are the tool suppliers who sell into that capacity. These sympathy names have no fresh print of their own, so they carry no EP score — but directionally they’re all expressing the same thesis: the AI-memory up-cycle is structural, not late. MU itself remains the one genuine fresh-EP, banked last night.
TECH
Bio-Techne · a clean takeout, stated plainly. Merck KGaA agreed to acquire Bio-Techne — a maker of research reagents, proteins, antibodies, and life-science instruments — for $73 per share in cash, an $11.3B enterprise value and a 36% premium, with both boards on board and closing targeted for late 2026 or early 2027. The stock’s +19% to ~$70 reflects the market pricing it toward the deal; the remaining ~4% is the spread to close, not upside. Per our M&A rule, there’s no multi-day runner thesis here — the price is bounded by the offer.
SNX
TD Synnex · the quality beat that needs volume to confirm. TD Synnex delivered a record quarter — EPS of $4.85 against a $4.11 estimate, revenue of $19.6B up 31% year-over-year and well above the ~$16.8B consensus — and raised its Q3 guide above the Street on the back of broad distribution strength and acceleration in its Hyve hyperscale/AI-server build business. That last point is why it matters: SNX is a direct beneficiary of the same AI-infrastructure capex driving Micron. The one caveat is mechanical — premarket volume is only ~0.5x average, which fails our EP confirmation gate, so the fundamentals are strong but the price action hasn’t validated the move yet.
KYMR
Kymera · an accelerated readout on the lead asset. Kymera announced an expedited timeline to share topline data from the Phase 2b trial of KT-621, an oral STAT6 degrader for atopic dermatitis — a large, competitive eczema market where an oral degrader would be differentiated. Pulling a data readout forward signals confidence and compresses the catalyst calendar; the +9% reflects the market repricing that nearer-term binary. Clinical-stage, so size to the binary nature of the readout.
BB
BlackBerry · a modest, clean beat. BlackBerry’s Q1 came in ahead — an EPS surprise of roughly +36% and revenue up ~9% — on its IoT/QNX automotive software and Secure Communications cybersecurity segments. It scored as a CAND (EP-γ 58): a real earnings beat with reasonable volume, but not the magnitude or cohort strength of a STRONG. A clean print riding into a risk-on tape.
Bottom line: Micron’s guide lit a sector-wide semiconductor rally, and the highest-quality new setup behind it is SNX’s record AI-server quarter — held back only by thin premarket volume. The biggest mover, TECH, is a closed Merck takeout, not a momentum trade.
Generated 9:15 AM ET (6:15 AM PT), Thu Jun 25 2026 · premarket run.
Your daily premarket briefing, brought to you by SignalDeck.live.
Not financial advice. SignalDeck surfaces catalysts and what price and volume reflect — how any of these trade is up to the market. Do your own diligence.